A 62-year-old man with HBsAg-positive cirrhosis and a 2.8 cm HCC nodule (BCLC stage A, no vascular invasion) is not a surgical candidate due to poor hepatic reserve. Which is the preferred drug of choice for locoregional therapy bridging to transplantation?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.